from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0894/-

LFCtreatmentdescriptionclass of inhibitor

-0.740

Amikacinug/mL Amikacintranslation

0.950

Cap5-10ug/mL Capreomycintranslation

-0.286

Rox10-50 ug/mL Roxithromycintranslation

0.457

SM2-5 ug/mL Streptomycintranslation

-0.332

Tet5-10 ug/mL Tetracyclinetranslation

0.112

Rif0.2-5ug/mL Rifampicintranscription

0.550

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.074

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.015

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

1.549

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.061

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.755

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.000

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.142

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

2.955

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.000

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-2.097

Nigericin50 uM Nigericinrespiration

-0.139

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

0.923

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.413

menadione6-10 ug/mL Menadionerespiration

0.253

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.319

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.075

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

2.169

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.000

NRP_1Non-replicating persistence stage 1dosRassociated

-0.394

Amp0.2mg/mL AmpicillincellWall

0.723

Cephalexin20-100 ug/mL CephalexincellWall

1.224

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.682

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.307

EMB10-20 ug/mL EthambutolcellWall

-0.275

Eta12-40 ug/mL EthionamidecellWall

0.163

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.378

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.196

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.222

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.100

BZA0.12 mg/mL BenzamidearomaticAmides

-0.105

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.223

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.334

H2O24 mM hydrogen peroxideDNAdamaging

0.891

Levo10 ug/mL LevofloxacinDNAdamaging

-0.073

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.000

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.531

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.233

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.233

Antimycin12.5-50 ug/mL Antimycin A?

-0.808

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.152

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.341

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.607

PA8240.2-2 ug/mL PA-824?

0.018

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.114

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.825

Verapamil50 uM Verapamil?

-1.359

mercaptoethanol2 mM 2-Mercaptoethanol?

0.000

methoxatin10-20 ug/mL Methoxatin?